These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3989700)

  • 1. Estimation of variance for harmonic mean half-lives.
    Lam FC; Hung CT; Perrier DG
    J Pharm Sci; 1985 Feb; 74(2):229-31. PubMed ID: 3989700
    [No Abstract]   [Full Text] [Related]  

  • 2. Translation of pharmacokinetics to clinical medicine.
    Dettli L
    J Pharmacokinet Biopharm; 1973 Oct; 1(5):403-18. PubMed ID: 4787617
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics and bioavailability.
    Wagner JG
    Triangle; 1975; 14(3-4):101-8. PubMed ID: 1209729
    [No Abstract]   [Full Text] [Related]  

  • 4. Intrasubject variation in elimination half-lives of drugs which are appreciably metabolized.
    Wagner JG
    J Pharmacokinet Biopharm; 1973 Apr; 1(2):165-73. PubMed ID: 4797185
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacokinetic models].
    Dahl S
    Tidsskr Nor Laegeforen; 1973 Jan; 93(3):157-62. PubMed ID: 4693373
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetic criteria for the evaluation of retard formulations.
    Meier J; Nüesch E; Schmidt R
    Eur J Clin Pharmacol; 1974 Oct; 7(6):429-32. PubMed ID: 4155170
    [No Abstract]   [Full Text] [Related]  

  • 7. Elementary pharmacokinetics in clinical practice 2: Basic concepts of drug pharmacokinetics.
    Paxton JW
    N Z Med J; 1981 Nov; 94(695):342-5. PubMed ID: 6950264
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of harmonic mean versus arithmetic mean clearance values.
    Schaaf LJ; Lam FC; Perrier DG
    J Pharm Sci; 1986 Apr; 75(4):427-9. PubMed ID: 3723367
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimation of half-life and exponential decay using a nomogram.
    Carson SW; DeVane CL
    Am J Hosp Pharm; 1983 Oct; 40(10):1696-8. PubMed ID: 6638037
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of change in elimination on varous parameters of the two-compartment open model.
    Jusko WJ; Gibaldi M
    J Pharm Sci; 1972 Aug; 61(8):1270-3. PubMed ID: 5050376
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of cholestasis on drug elimination: pharmacokinetics.
    Harrison LI; Gibaldi M
    J Pharm Sci; 1976 Sep; 65(9):1346-8. PubMed ID: 966151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacokinetic model for simulating drug concentrations in tissues or fluids and its application to antibiotics.
    Mizuta E; Tsubotani A
    Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2974-82. PubMed ID: 4085056
    [No Abstract]   [Full Text] [Related]  

  • 13. [Significance of pharmacokinetics in pharmacotherapy and pharmacology].
    Danek A
    Folia Med Cracov; 1974; 16(3):355-66. PubMed ID: 4410871
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug therapy: drug disposition in old age.
    Greenblatt DJ; Sellers EM; Shader RI
    N Engl J Med; 1982 May; 306(18):1081-8. PubMed ID: 7040951
    [No Abstract]   [Full Text] [Related]  

  • 15. New generalized equations for multiple dose kinetics by i.v. injection.
    Hajratwala BR
    Pharmazie; 1976; 31(10):731-3. PubMed ID: 1019197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic aspects of drug metabolism.
    Gibaldi M
    Ann N Y Acad Sci; 1971 Jul; 179():19-31. PubMed ID: 4936775
    [No Abstract]   [Full Text] [Related]  

  • 17. Simulation of pharmacokinetic behaviour of drug-cyclodextrin complexes.
    Habon I; Fritsch S; Szejtli J
    Pharmazie; 1984 Dec; 39(12):830-4. PubMed ID: 6531392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence of pharmacokinetic parameters on the body weight.
    Weiss M; Sziegoleit W; Förster W
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):572-5. PubMed ID: 598952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On predictions of free antibiotic (cefazolin) concentrations in extravascular fluids from 'logarithmic mean serum concentrations'.
    Gonda I
    J Antimicrob Chemother; 1982 Jan; 9(1):53-6. PubMed ID: 7061355
    [No Abstract]   [Full Text] [Related]  

  • 20. Estimation of population pharmacokinetic parameters using destructively obtained experimental data: a simulation study of the one-compartment open model.
    Lindstrom FT; Birkes DS
    Drug Metab Rev; 1984; 15(1-2):195-264. PubMed ID: 6745082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.